|
G |
Braf |
B-Raf proto-oncogene, serine/threonine kinase |
severity |
ISO |
associated with colorectal cancer;DNA:missense mutation:cds:p.V600E (human) associated with skin melanoma;DNA:missense mutations:cds: associated with colorectal cancer;DNA:mutations:multiple associated with colorectal cancer;DNA:mutation:cds: associated with colorectal cancer;DNA:missense mutations:cds:pV599E,p.V600E (human) |
RGD |
PMID:22331825 PMID:23010994 PMID:26775732 PMID:27737491 PMID:28787433 |
RGD:11554843 RGD:14696791 RGD:15039394 RGD:18337264 RGD:18337265 |
NCBI chrNW_004936592:4,728,371...4,833,830
Ensembl chrNW_004936592:4,737,011...4,834,664
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
treatment |
ISO |
associated with Animal Mammary Neoplasms; |
RGD |
PMID:15692764 |
RGD:14995455 |
NCBI chrNW_004936490:253,279...259,947
Ensembl chrNW_004936490:253,034...259,965
|
|
G |
Ccnd2 |
cyclin D2 |
|
ISO |
associated with colorectal cancer;protein:increased expression:colorectum |
RGD |
PMID:19508551 |
RGD:151665111 |
NCBI chrNW_004936606:4,474,801...4,496,158
Ensembl chrNW_004936606:4,474,749...4,496,810
|
|
G |
Ccng1 |
cyclin G1 |
treatment |
ISO |
human cells in mouse model |
RGD |
PMID:10910035 |
RGD:151356987 |
NCBI chrNW_004936515:614,287...621,213
Ensembl chrNW_004936515:614,290...619,963
|
|
G |
Cd44 |
CD44 molecule (IN blood group) |
|
ISO |
associated with Breast Neoplasm;protein:increased expression:liver |
RGD |
PMID:17991717 |
RGD:2289349 |
NCBI chrNW_004936533:2,949,026...3,033,166
|
|
G |
Chd4 |
chromodomain helicase DNA binding protein 4 |
ameliorates |
ISO |
associated with human colon adenocarcinoma cells in a mouse model |
RGD |
PMID:28486105 |
RGD:153323299 |
NCBI chrNW_004936709:1,183,243...1,214,144
Ensembl chrNW_004936709:1,183,254...1,214,149
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
treatment |
ISO |
associated with colon carcinoma; |
RGD |
PMID:30381616 |
RGD:27095891 |
NCBI chrNW_004936676:60,869...63,028
Ensembl chrNW_004936676:60,621...63,106
|
|
G |
Cxcl12 |
C-X-C motif chemokine ligand 12 |
ameliorates |
ISO |
associated with colorectal cancer; human cells in mouse model |
RGD |
PMID:30789971 |
RGD:151893289 |
NCBI chrNW_004936617:4,224,131...4,239,080
Ensembl chrNW_004936617:4,224,131...4,238,796
|
|
G |
Cxcr4 |
C-X-C motif chemokine receptor 4 |
ameliorates |
ISO |
associated with colorectal cancer; human cells in mouse model human cells in mouse model; associated with colorectal cancer |
RGD |
PMID:29436696 PMID:30789971 |
RGD:151893289 RGD:152023643 |
NCBI chrNW_004936469:39,794,613...39,798,448
Ensembl chrNW_004936469:39,794,584...39,798,459
|
|
G |
Daxx |
death domain associated protein |
exacerbates |
ISO |
associated with colon cancer; mRNA:decreased expression:liver (human) associated with pancreatic endocrine carcinoma;DNA:mutations:CDS:multiple (human) associated with neuroendocrine tumor;DNA:mutations:CDS:multiple (human) |
RGD |
PMID:30339629 PMID:30342802 PMID:31942198 |
RGD:152025194 RGD:152025199 RGD:152025203 |
NCBI chrNW_004936476:25,546,091...25,550,390
Ensembl chrNW_004936476:25,546,036...25,550,392
|
|
G |
Ddr1 |
discoidin domain receptor tyrosine kinase 1 |
treatment |
ISO |
human cells in mouse model; nilotinib mRNA:increased expression:liver (mouse) |
RGD |
PMID:29438985 PMID:30666650 PMID:33110221 |
RGD:151347537 RGD:151347685 RGD:151347840 |
NCBI chrNW_004936837:523,227...538,799
Ensembl chrNW_004936837:523,266...538,833
|
|
G |
Ddr2 |
discoidin domain receptor tyrosine kinase 2 |
ameliorates |
ISO |
associated with colon carcinoma associated with melanoma; |
RGD |
PMID:21701781 PMID:22071959 |
RGD:150429701 RGD:150429713 |
NCBI chrNW_004936831:799,948...946,139
Ensembl chrNW_004936831:865,965...946,139
|
|
G |
Dock6 |
dedicator of cytokinesis 6 |
ameliorates |
ISO |
associated with stomach cancer; |
RGD |
PMID:29587866 |
RGD:155791564 |
NCBI chrNW_004936659:1,341,144...1,394,484
Ensembl chrNW_004936659:1,341,331...1,379,728
|
|
G |
Fbxw7 |
F-box and WD repeat domain containing 7 |
disease_progression |
ISO |
associated with colorectal cancer; |
RGD |
PMID:28846828 |
RGD:21408566 |
NCBI chrNW_004936689:2,261,163...2,449,951
Ensembl chrNW_004936689:2,259,477...2,344,764
|
|
G |
Fgfr1 |
fibroblast growth factor receptor 1 |
|
ISO |
associated with colorectal cancer;mRNA:increased expression:colorectal mucosa: |
RGD |
PMID:19082464 |
RGD:25330357 |
NCBI chrNW_004936710:1,760,365...1,815,269
Ensembl chrNW_004936710:1,760,089...1,815,508
|
|
G |
Fosl2 |
FOS like 2, AP-1 transcription factor subunit |
|
ISO |
human cells in mouse model |
RGD |
PMID:30114390 |
RGD:153344554 |
NCBI chrNW_004936493:4,308,683...4,327,102
Ensembl chrNW_004936493:4,304,395...4,327,179
|
|
G |
Gpc3 |
glypican 3 |
|
ISO |
protein:increased expression:blood serum (human) |
RGD |
PMID:28801286 |
RGD:243065135 |
NCBI chrNW_004936691:1,060,013...1,459,736
Ensembl chrNW_004936691:1,059,994...1,459,740
|
|
G |
Hmbs |
hydroxymethylbilane synthase |
|
ISO |
associated with colon adenocarcinoma;protein:decreased activity:liver(rat) |
RGD |
PMID:1386052 |
RGD:25440496 |
NCBI chrNW_004936542:4,037,888...4,046,089
Ensembl chrNW_004936542:4,037,201...4,050,810
|
|
G |
Il2 |
interleukin 2 |
treatment |
ISO |
associated with Colorectal Neoplasms, Carcinoma, Hepatocellular; associated with colon carcinoma |
RGD |
PMID:9354462 PMID:11591892 |
RGD:14928215 RGD:8663446 |
NCBI chrNW_004936662:1,594,953...1,599,625
Ensembl chrNW_004936662:1,594,953...1,599,625
|
|
G |
Iqsec1 |
IQ motif and Sec7 domain ArfGEF 1 |
|
ISO |
human cells in mouse model |
RGD |
PMID:22662237 |
RGD:153344589 |
NCBI chrNW_004936898:318,564...425,785
Ensembl chrNW_004936898:337,400...425,859
|
|
G |
LOC101964975 |
interleukin-8 |
|
ISO |
associated with colorectal cancer; human colon adenocarcinoma cells in a mouse model |
RGD |
PMID:29679563 |
RGD:26884358 |
NCBI chrNW_004936598:1,779,471...1,781,353
Ensembl chrNW_004936598:1,779,471...1,781,353
|
|
G |
LOC101968921 |
angiotensin-converting enzyme |
|
ISO |
associated with colorectal cancer;mRNA:increased expression:liver (mouse) |
RGD |
PMID:20380732 |
RGD:25671446 |
NCBI chrNW_004936541:4,157,847...4,178,156
Ensembl chrNW_004936541:4,157,393...4,178,177
|
|
G |
Map2k7 |
mitogen-activated protein kinase kinase 7 |
|
ISO |
associated with colon cancer;protein:increased expression:colon (human) |
RGD |
PMID:24533778 |
RGD:155259116 |
NCBI chrNW_004936588:4,882,191...4,891,807
Ensembl chrNW_004936588:4,882,184...4,892,071
|
|
G |
Mpl |
MPL proto-oncogene, thrombopoietin receptor |
exacerbates severity |
ISO |
associated with pancreatic cancer; protein:increased expression:liver, pancreas (human) associated with pancreatic ductal adenocarcinoma; human cells in mouse model associated with colorectal carcinoma;protein:increased expression:colorectum (human) |
RGD |
PMID:23747337 PMID:30770989 |
RGD:126925751 RGD:126925752 |
NCBI chrNW_004936474:24,744,673...24,757,189
Ensembl chrNW_004936474:24,744,673...24,757,085
|
|
G |
Nras |
NRAS proto-oncogene, GTPase |
susceptibility |
ISO |
human gene in a mouse model;DNA:missense mutations:cds:p.G12V, p.Q61K (human) associated with melanoma;DNA:mutations: exons (human) associated with colorectal cancer;DNA:mutations:exons (human) |
RGD |
PMID:26799184 PMID:28011498 PMID:28787433 |
RGD:14696774 RGD:14696791 RGD:14696792 |
NCBI chrNW_004936627:73,413...82,590
Ensembl chrNW_004936627:73,413...82,590
|
|
G |
Ptprb |
protein tyrosine phosphatase receptor type B |
treatment |
ISO |
mouse tumor cells in mouse recipient |
RGD |
PMID:31348125 |
RGD:151660353 |
NCBI chrNW_004936545:8,150,766...8,235,674
Ensembl chrNW_004936545:8,147,291...8,235,715
|
|
G |
Rictor |
RPTOR independent companion of MTOR complex 2 |
disease_progression |
ISO |
mRNA:increased expression:liver (human) |
RGD |
PMID:30404068 |
RGD:152995463 |
NCBI chrNW_004936518:3,198,312...3,314,393
Ensembl chrNW_004936518:3,198,337...3,310,000
|
|
G |
Rnf43 |
ring finger protein 43 |
|
ISO |
associated with colorectal adenocarcinoma;mRNA:increased expression:liver (human) |
RGD |
PMID:28789449 |
RGD:151361221 |
NCBI chrNW_004936490:4,660,904...4,742,669
Ensembl chrNW_004936490:4,683,725...4,741,828
|
|
G |
Slc3a2 |
solute carrier family 3 member 2 |
severity |
ISO |
associated with colon adenocarcinoma |
RGD |
PMID:11745822 |
RGD:151361130 |
NCBI chrNW_004936581:424,801...441,592
|
|
G |
Slc7a5 |
solute carrier family 7 member 5 |
severity |
ISO |
associated with colon adenocarcinoma associated with colon cancer |
RGD |
PMID:11718450 PMID:11745822 |
RGD:151361129 RGD:151361130 |
NCBI chrNW_004936641:1,513,110...1,538,955
|
|
G |
Smad4 |
SMAD family member 4 |
treatment |
ISO |
associated with colorectal carcinoma;protein:decreased expression:colorectum: associated with colorectal carcinoma; DNA:mutations: : |
RGD |
PMID:17390050 PMID:29551247 |
RGD:18937000 RGD:21066338 |
NCBI chrNW_004936497:12,242,869...12,278,012
Ensembl chrNW_004936497:12,249,140...12,278,123
|
|
G |
Sox30 |
SRY-box transcription factor 30 |
ameliorates |
ISO |
|
RGD |
PMID:29739711 |
RGD:151660333 |
NCBI chrNW_004936515:5,501,315...5,537,946
Ensembl chrNW_004936515:5,458,393...5,537,946
|
|
G |
Src |
SRC proto-oncogene, non-receptor tyrosine kinase |
disease_progression |
ISO |
associated with colon cancer;protein:increased activity:colon |
RGD |
PMID:7678609 |
RGD:150521542 |
NCBI chrNW_004936561:3,826,802...3,844,406
Ensembl chrNW_004936561:3,825,787...3,844,483
|
|
G |
Vegfa |
vascular endothelial growth factor A |
|
ISO |
associated with colorectal carcinoma;mRNA,protein:increased expression:liver: |
RGD |
PMID:22156924 |
RGD:15014782 |
NCBI chrNW_004936476:16,245,134...16,261,180
Ensembl chrNW_004936476:16,247,100...16,260,673
|
|